Targeting the tumor vasculature to enhance T cell activity

Curr Opin Immunol. 2015 Apr:33:55-63. doi: 10.1016/j.coi.2015.01.011. Epub 2015 Feb 6.


T cells play a critical role in tumor immune surveillance as evidenced by extensive mouse-tumor model studies as well as encouraging patient responses to adoptive T cell therapies and dendritic cell vaccines. It is well established that the interplay of tumor cells with their local cellular environment can trigger events that are immunoinhibitory to T cells. More recently it is emerging that the tumor vasculature itself constitutes an important barrier to T cells. Endothelial cells lining the vessels can suppress T cell activity, target them for destruction, and block them from gaining entry into the tumor in the first place through the deregulation of adhesion molecules. Here we review approaches to break this tumor endothelial barrier and enhance T cell activity.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Humans
  • Immunotherapy, Adoptive / methods
  • Lymphocyte Activation / drug effects
  • Lymphocyte Activation / immunology*
  • Molecular Targeted Therapy
  • Neoplasms / immunology*
  • Neoplasms / metabolism
  • Neoplasms / pathology*
  • Neoplasms / therapy
  • Neovascularization, Pathologic / immunology*
  • Neovascularization, Pathologic / metabolism
  • Neovascularization, Pathologic / therapy
  • T-Lymphocytes / drug effects
  • T-Lymphocytes / immunology*
  • T-Lymphocytes / metabolism